| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 09/05/2002 | US20020123520 3',5'-cyclic nucleotide phosphodiesterases (PDEs); disease related to eosinophils, such as asthma, chronic bronchitis, and chronic obstructuive pulmonary disease |
| 09/05/2002 | US20020123513 Administering indole-2-carboxylic amide derivatives of given formula |
| 09/05/2002 | US20020123504 In an inert carrier; instant release; treating allergic rhinitis and other histamine-induced disorders |
| 09/05/2002 | US20020123493 For therapy and prophylaxis of neuronal damage |
| 09/05/2002 | US20020123484 For therapy of immunologic disorders such as transplant rejection, rheumatoid arthritis. multiple sclerosis, inflammatory bowel disease, lupus, graft vs. host disease |
| 09/05/2002 | US20020123473 For therapy of asthma |
| 09/05/2002 | US20020123047 dexB |
| 09/05/2002 | US20020122833 Herbal compositions for treating immunological disorders |
| 09/05/2002 | US20020122814 Nitric oxide associated with and releasable from a polyurea network formed from reaction (a) a polyisocyanate; (b) an amine donor; (c) an isocyanatosilane adduct having a terminal isocyanate group and an alkoxysilane group |
| 09/05/2002 | DE10109861A1 Neuartige seitenkettenhalogenierte Aminodicarbonsäurederivate Novel side-chain halogenated Aminodicarbonsäurederivate |
| 09/05/2002 | DE10109859A1 Neuartige Aminodicarbonsäurederivate Novel Aminodicarbonsäurederivate |
| 09/05/2002 | DE10106852A1 Entzündungshemmende Verbindungen Anti-inflammatory compounds |
| 09/04/2002 | EP1236800A2 Nucleic acids encoding interferon alpha 2, containing single nucleotide polymorphisms and methods of use thereof |
| 09/04/2002 | EP1236725A1 Novel 1,8-naphthyridin-2(1h)-one derivatives |
| 09/04/2002 | EP1236723A1 Sulfamide derivatives useful as beta3 agonists and pharmaceutical uses thereof |
| 09/04/2002 | EP1236473A2 Self-assembling polynucleotide delivery system |
| 09/04/2002 | EP1236468A1 Sulfonylaminocarbonyl derivatives for the treatment of nuclear factor-kappa B mediated diseases and disorders |
| 09/04/2002 | EP1235934A2 Screening method for candidate drugs |
| 09/04/2002 | EP1235860A2 G-protein coupled receptors |
| 09/04/2002 | EP1235851A2 Regulators of the hedgehog pathway, compositions and uses related thereto |
| 09/04/2002 | EP1235849A2 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 09/04/2002 | EP1235846A1 Uteroglobin-like polynucleotides, polypeptides, and antibodies |
| 09/04/2002 | EP1235844A1 28 human secreted proteins |
| 09/04/2002 | EP1235838A1 23 human secreted proteins |
| 09/04/2002 | EP1235830A2 PYRROLO 2,3-d]PYRIMIDINE COMPOUNDS |
| 09/04/2002 | EP1235825A1 Novel benzoimidazole derivatives useful as antiproliferative agents |
| 09/04/2002 | EP1235824A1 Vitamin d analogues |
| 09/04/2002 | EP1235814A1 3,4-DIHYDRO-(1H)QUINAZOLIN-2-ONE COMPOUNDS AS CSBP/p38 KINASE INHIBITORS |
| 09/04/2002 | EP1235812A2 Pyrimidine derivatives as selective inhibitors of cox-2 |
| 09/04/2002 | EP1235809A1 Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocines and the use thereof as medicaments |
| 09/04/2002 | EP1235807A1 B-amino acid-, aspartic acid- and diaminopropionic-based inhibitors of factor xa |
| 09/04/2002 | EP1235803A1 Urea compounds having muscarinic receptor antagonist activity |
| 09/04/2002 | EP1235802A1 Carbamate derivatives having muscarinic receptor antagonist activity |
| 09/04/2002 | EP1235793A2 Vla-4 integrin antagonists |
| 09/04/2002 | EP1235787A1 $g(b)2-ADRENERGIC RECEPTOR AGONISTS |
| 09/04/2002 | EP1235618A2 Bioconjugation in vivo to pulmonary or blood components |
| 09/04/2002 | EP1235594A2 Inhibition of secretion from non-neuronal cells |
| 09/04/2002 | EP1056759B1 2-(purin-9-yl) -tetrahydrofuran-3, 4-diol derivatives |
| 09/04/2002 | EP1037888B1 (e)-3-[1-n-butyl- 5-[2-(2-carboxyphenyl)methoxy- 4-chlorophenyl]-1h- pyrazol-4-yl]-2- [(5- methoxy-2,3- dihydrobenzofuran-6-yl)methyl]- prop-2-enoic acid monoargininyl salt |
| 09/04/2002 | EP1036076B1 Novel compounds |
| 09/04/2002 | EP1005471B1 Pyrazolo(3,4-d)pyrimidines with anticonvulsive and antiallergic/antiasthmatic action |
| 09/04/2002 | EP0858459B1 Novel acid pyrazole derivatives, preparation method therefor, use thereof as drugs, novel use therefor, and pharmaceutical compositions containing such derivatives |
| 09/04/2002 | EP0809636B1 Substituted isoxazoles for the treatment of inflammation |
| 09/04/2002 | EP0682526B1 PULMONARY ADMINISTRATION OF THE SOLUBLE COMPLEM RECEPTOR TYPE 1 sCR1 |
| 09/04/2002 | EP0590006B1 Synthetic pulmonary surfactant peptides |
| 09/04/2002 | CN1367792A Somatostatin agonists |
| 09/04/2002 | CN1367790A Moraxella cattarrhalis BASB114 polypeptide antigens and uses thereof |
| 09/04/2002 | CN1367787A Water soluble SDZ-RAD esters |
| 09/04/2002 | CN1367778A Novel carboxylic acid derivatives with 5,6 substitutedpyrimidine ring, their production and utilization thereof as endothelin receptor antagonists |
| 09/04/2002 | CN1367700A Small peptides and method for downregulation of lgE |
| 09/04/2002 | CN1367018A Compound preparation of staphylococcolysis enzyme and its preparation method and application |
| 09/04/2002 | CN1367012A Peach and apricot health-care food for curing cough and asthma |
| 09/04/2002 | CN1366988A Health-care tea as cigarette companion and its preparation method |
| 09/04/2002 | CN1366981A Application of agave americana and its using method |
| 09/04/2002 | CN1366979A Notoginseng flower throat-mostening medicine |
| 09/04/2002 | CN1366978A Nane common cold-fever-abating preparation medicine and preparation method |
| 09/04/2002 | CN1366970A Nano star anise preparation medicine and preparation method |
| 09/04/2002 | CN1366966A Nano pinellia preparation medicine and preparation method |
| 09/04/2002 | CN1366965A Nano wind-cold Ganmaoning preparation medicine and preparation method |
| 09/04/2002 | CN1366963A Nano Ermuansou preparation medicine and preparation method |
| 09/04/2002 | CN1366962A Nano Erding preparation medicine and preparation method |
| 09/04/2002 | CN1366954A Nano Xuanmai Ganju preparation medicine and preparation method |
| 09/04/2002 | CN1366942A Nano Chuanbei Luohan cough-relieving preparation medicine and preparation method |
| 09/04/2002 | CN1366941A Nano Cuitang preparation medicine and preparation method |
| 09/04/2002 | CN1366940A Nano indigo and clamshell preparation medicine and preparation method |
| 09/04/2002 | CN1366938A Nano Huishengzaizao preparation medicine and preparation method |
| 09/04/2002 | CN1366936A Nano antelope lung-clearing preparation medicine and preparation method |
| 09/04/2002 | CN1366932A Nano Jinshuibao preparation medicine and preparation method |
| 09/04/2002 | CN1366925A Nano stomach-clearing coptis preparation medicine and preparation method |
| 09/04/2002 | CN1366924A Nano throat-benefiting preparation medicine and preparation method |
| 09/04/2002 | CN1366922A Nano Lusike preparation medicine and preparation method |
| 09/04/2002 | CN1366921A Nano Juhong preparation medicine and preparation method |
| 09/04/2002 | CN1366920A Nano Jieji'ningsou preparation medicine and preparation method |
| 09/04/2002 | CN1366916A Nano plum blossom tongue preparation medicine and preparation method |
| 09/04/2002 | CN1366910A Nano bovine bezoar fire-clearing preparation medicine and preparation method thereof |
| 09/04/2002 | CN1366909A Nano bovine bezoar anti-inflammatory preparation medicine and preparation method thereof |
| 09/04/2002 | CN1366907A Nano Jianmin throat-benefiting preparation medicine and preparation method thereof |
| 09/04/2002 | CN1366904A Nano drool-controlling preparation medicine and preparation method thereof |
| 09/04/2002 | CN1366903A Nano lung-benefiting preparation medicine and preparation method thereof |
| 09/04/2002 | CN1366901A Nano liyanling preparation medicine and preparation method thereof |
| 09/04/2002 | CN1366899A Nano dizziness-clearing preparation medicine and preparation method thereof |
| 09/04/2002 | CN1366898A Nano jizhi preparation medicine and preparation method thereof |
| 09/04/2002 | CN1366894A Nano lung-clearing anti-inflammatory preparation medicine and preparation method thereof |
| 09/04/2002 | CN1366893A Nano qingfei yihuo preparation medicine and preparation method thereof |
| 09/04/2002 | CN1366892A Nano qinghouyan preparation medicine and preparation method thereof |
| 09/04/2002 | CN1366891A Nano clear and quiet preparation medicine and preparation method thereof |
| 09/04/2002 | CN1366889A Nano liyan jiedu preparation medicine and preparation method thereof |
| 09/04/2002 | CN1366880A Sophorcarpidine alkaloid and decongestant compound medicine and its preparation method |
| 09/04/2002 | CN1090190C Heterocycle-condensed morphinoid derivatives and its preparing method and use |
| 09/04/2002 | CN1090189C Pyrazolopyrimidines type compound |
| 09/04/2002 | CN1090188C Benzonaphthyrindines compound |
| 09/04/2002 | CN1090027C Immunity-strengthening and infection-preventing medicine |
| 09/04/2002 | CN1090026C Novel medicine for stopping narcotics and preparing method thereof |
| 09/03/2002 | US6444829 (2s,4r)-4-mercapto-1-(naphthalene-2-sulfonyl)-pyrrolidine-2 -carboxylic acid n'-isobutyl-n'-(4-methyl-benzenesulfonyl)-hydrazide, for example; inhibitors of metalloproteases, e.g. zinc proteases; vasodilators |
| 09/03/2002 | US6444809 Antihistamines |
| 09/03/2002 | US6444696 1-aryl or heteroaryl substituted 5-amino-4 carbonylpyrazole derivatives; antiinflammatory agents |
| 09/03/2002 | US6444686 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 09/03/2002 | US6444679 Neurological and gastrointestinal disorders; delta opioid ligands or opioid receptors |
| 09/03/2002 | US6444677 5-membered heteroaryl substituted 1,4-dihydropyridine compounds as bradykinin antagonists |
| 09/03/2002 | US6444657 2-(phosphonomethyl)pentanedioic acid; 2-(2-sulfanylethyl) pentanedioic acid; epithelial tissue scarring, collagen vascular disease, fibroproliferation, connective tissue disorder, respiratory distress syndrome; tgf regulator |